| Security Name | Asset Type |
Shares or Principal Amount |
Market Value |
Percent of Net Assets |
|---|---|---|---|---|
| Capital Group Central Cash Fund | Short Term | 2,913,316 | $291,302,472.00 | 1.37% |
| Bank of America Corp. 5.045% 2/6/2037 (USD-SOFR + 1.13% on 2/6/2036) | Fixed Income | 131,044,000 | $129,353,270.00 | 0.61% |
| Goldman Sachs Group, Inc. 4.939% 10/21/2036 (USD-SOFR + 1.33% on 10/21/2035) | Fixed Income | 128,801,000 | $124,779,704.00 | 0.59% |
| NFE Financing, LLC 12.00% 11/15/2029 | Fixed Income | 209,996,299 | $95,150,373.00 | 0.45% |
| MPT Operating Partnership, LP 8.50% 2/15/2032 | Fixed Income | 89,427,000 | $90,732,813.00 | 0.43% |
| U.S. Treasury 3.875% 3/31/2031 | Fixed Income | 82,323,800 | $82,069,757.00 | 0.38% |
| Jefferies Financial Group, Inc. 5.50% 2/15/2036 | Fixed Income | 82,000,000 | $78,751,406.00 | 0.37% |
| AbbVie, Inc. 5.05% 3/15/2034 | Fixed Income | 74,959,000 | $76,104,074.00 | 0.36% |
| Connect Finco SARL 9.00% 9/15/2029 | Fixed Income | 72,270,000 | $76,012,863.00 | 0.36% |
| U.S. Treasury 4.125% 2/15/2036 | Fixed Income | 77,858,000 | $76,647,549.00 | 0.36% |
| Oracle Corp. 5.20% 9/26/2035 | Fixed Income | 76,221,000 | $71,533,332.00 | 0.34% |
| Mars, Inc. 5.20% 3/1/2035 | Fixed Income | 66,754,000 | $67,413,797.00 | 0.32% |
| Oracle Corp. 5.70% 2/4/2036 | Fixed Income | 66,668,000 | $64,129,416.00 | 0.3% |
| Peraton Corp., Term Loan B, (3-month USD CME Term SOFR + 3.85%) 7.517% 2/1/2028 | Fixed Income | 74,396,327 | $63,577,836.00 | 0.3% |
| CVS Health Corp. 5.45% 9/15/2035 | Fixed Income | 58,382,000 | $58,630,007.00 | 0.28% |